Literature DB >> 1891103

Inflammation at the neuromuscular junction in myasthenia gravis.

R A Maselli1, D P Richman, R L Wollmann.   

Abstract

To better define the pathogenic mechanisms in the antibody-mediated autoimmune disease myasthenia gravis (MG), we analyzed the morphology and electrophysiology of the neuromuscular junction in anconeus muscle biopsy specimens from eight patients with MG and seven control subjects. There were inflammatory cells at the neuromuscular junction in seven of the eight biopsies from MG patients. The endplate index (length of the postsynaptic membrane divided by the length of the apposed presynaptic membrane) was abnormally reduced in all the MG patients, and fiber type grouping, suggestive of reinnervation, was present in six of the eight MG patients. Intracellular recording revealed diminished amplitude of miniature endplate potentials and miniature endplate currents in the MG patients compared with the controls. The time constant of decay of miniature endplate currents did not differ from that of controls, suggesting no change in mean channel open time of the acetylcholine receptor. The endplate receptor sensitivity to iontophoretically applied acetylcholine was also decreased in MG patients compared with controls. The quantal content of neurally evoked endplate potentials was reduced in six of the eight MG patients, demonstrating abnormal presynaptic function as well. The presence of inflammatory cells at the neuromuscular junctions of limb muscles in MG reconciles an apparent disparity between the animal model of MG, experimental autoimmune myasthenia gravis, and the human disease. This study also demonstrates a frequent presynaptic component to the abnormal neuromuscular transmission in MG.

Entities:  

Mesh:

Year:  1991        PMID: 1891103     DOI: 10.1212/wnl.41.9.1497

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

Review 1.  Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Authors:  Y M Graus; M H De Baets
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

2.  Reduction of calcium currents by Lambert-Eaton syndrome sera: motoneurons are preferentially affected, and L-type currents are spared.

Authors:  K D García; K G Beam
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

Review 3.  B cells in the pathophysiology of myasthenia gravis.

Authors:  John S Yi; Jeffrey T Guptill; Panos Stathopoulos; Richard J Nowak; Kevin C O'Connor
Journal:  Muscle Nerve       Date:  2017-09-30       Impact factor: 3.217

Review 4.  Neuromuscular transmission failure in myasthenia gravis: decrement of safety factor and susceptibility of extraocular muscles.

Authors:  Alessandro Serra; Robert L Ruff; Richard John Leigh
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

5.  How myasthenia gravis alters the safety factor for neuromuscular transmission.

Authors:  Robert L Ruff; Vanda A Lennon
Journal:  J Neuroimmunol       Date:  2008-07-15       Impact factor: 3.478

6.  Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes.

Authors:  M W Nicolle; B Nag; S D Sharma; N Willcox; A Vincent; D J Ferguson; J Newsom-Davis
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

7.  A Chemically Defined Common Medium for Culture of C2C12 Skeletal Muscle and Human Induced Pluripotent Stem Cell Derived Spinal Spheroids.

Authors:  Rachel R Besser; Annie C Bowles; Ahmad Alassaf; Daniel Carbonero; Renata Maciel; Mario Saporta; Ashutosh Agarwal
Journal:  Cell Mol Bioeng       Date:  2020-06-10       Impact factor: 2.321

8.  IL-6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse.

Authors:  Matthew C Kostek; Kanneboyina Nagaraju; Emidio Pistilli; Arpana Sali; San-Huei Lai; Brad Gordon; Yi-Wen Chen
Journal:  BMC Musculoskelet Disord       Date:  2012-06-20       Impact factor: 2.362

Review 9.  Differential diagnosis of idiopathic inflammatory myopathies.

Authors:  Alan N Baer
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.686

10.  Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction.

Authors:  D Gu; L Wogensen; N A Calcutt; C Xia; S Zhu; J P Merlie; H S Fox; J Lindstrom; H C Powell; N Sarvetnick
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.